Leczenie dyslipidemii w Polsce — interdyscyplinarne stanowisko grupy ekspertów wsparte przez Sekcję Farmakoterapii Sercowo-Naczyniowej Polskiego Towarzystwa Kardiologicznego. IV Deklaracja Sopocka

Szymański, Filip M.; Mickiewicz, Agnieszka; Dzida, Grzegorz; Gorczyca, Iwona; Kozłowski, Dariusz; Widecka, Krystyna; Krasiński, Zbigniew; Kobayashi, Adam; Hering, Dagmara; Mizia‐Stec, Katarzyna; Kasprzak, Jarosław D.; Zubilewicz, Tomasz; Koziński, Marek; Płatek, Anna E.; Ryś-Czaporowska, Anna; Chełstowska, Beata; Grajek, Stefan; Wełnicki, Marcin; Mamcarz, Artur; Barylski, Marcin; Wożakowska−Kapłon, Beata; Jaguszewski, Miłosz; Gruchała, Marcin; Filipiak‬, Krzysztof J.

doi:10.5603/chsin.2021.0011

Cited by 4 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…These guidelines indicate that garlic (5-6 g/day dose) may have a mild to moderate reduction in serum LDL cholesterol (5-10% of the baseline concentration). The recommendation for the use of garlic in patients with lipid disorders is class IIa (should be considered) and the level of evidence A (data from many randomized clinical trials or meta-analyses) [41,42].…”

Section: Discussionmentioning

confidence: 99%

Garlic for arterial hypertension and hypercholesterolaemia. Review of literature studies and clinical studies

et al. 2021

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Garlic for arterial hypertension and hypercholesterolaemia. Review of literature studies and clinical studies

et al. 2021

Self Cite

View full text Add to dashboard Cite

show abstract

“…Jednocześnie podkreślając, że wyroby te nadal zawierają nikotynę, która jest sama w sobie szkodliwa dla organizmu człowieka (ryc. 1) [41,42].…”

Section: Czym Jest Mrtp?unclassified

Is there an optimal management of nicotine addiction in patients with chronic obstructive pulmonary disease and asthma? Expert consensus

Jahnz-Różyk¹,

Pawliczak²,

Balsam³

et al. 2023

pja

View full text Add to dashboard Cite

“…Polish scientific societies also recognise the rationale for using innovative products to reduce exposure to tobacco smoke, both for smokers and bystanders previously exposed to passive smoking. At the same time, they emphasize that these products still contain nicotine, which is harmful to the human body in itself (Figure 1) [41,42].…”

Section: What Is Mrtp?mentioning

confidence: 99%

Is there an optimal management system for nicotine-dependent patients with chronic obstructive pulmonary disease and asthma? Expert consensus

Jahnz-Różyk¹,

Pawliczak²,

Balsam³

et al. 2023

pja

View full text Add to dashboard Cite

Nicotinism remains one of the main causes of morbidity and mortality in Poland and worldwide. A particularly vulnerable group of patients are those with respiratory diseases -especially chronic obstructive pulmonary disease and asthma. Smoking cigarettes is associated with a poorer prognosis and a difficult treatment process for the underlying disease. Anti-smoking therapy has limited effectiveness. One of the strategies that breaks through to the mainstream is harm reduction management. Some of the methods available today include systems for heating tobacco. However, attention is drawn to the risks associated with the smoking of traditional cigarettes and the use of 'heat-not-burn' systems. The management of nicotine-dependent patients and lung disease requires a multi-profile, holistic approach, individually tailored to each patient.

show abstract

Leczenie dyslipidemii w Polsce — interdyscyplinarne stanowisko grupy ekspertów wsparte przez Sekcję Farmakoterapii Sercowo-Naczyniowej Polskiego Towarzystwa Kardiologicznego. IV Deklaracja Sopocka

Cited by 4 publications

References 0 publications

Garlic for arterial hypertension and hypercholesterolaemia. Review of literature studies and clinical studies

Garlic for arterial hypertension and hypercholesterolaemia. Review of literature studies and clinical studies

Is there an optimal management of nicotine addiction in patients with chronic obstructive pulmonary disease and asthma? Expert consensus

Is there an optimal management system for nicotine-dependent patients with chronic obstructive pulmonary disease and asthma? Expert consensus

Contact Info

Product

Resources

About